The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Dupilumab, a fully human monoclonal antibody, binds to the α-subunit of the interleukin (IL)-4 receptor and blocks the signaling pathway of IL-4 and IL-13. 1 It is the first antibody-based treatment that became available for the treatment of AD and is also registered for severe T2 asthma. 2 Several studies reported improved clinical outcomes and su...
Alternative Titles
Full title
The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4b890086b4214a3f96d521429d35354e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b890086b4214a3f96d521429d35354e
Other Identifiers
ISSN
2045-7022
E-ISSN
2045-7022
DOI
10.1002/clt2.12219
